VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study.
Yuen MF, Lim YS, Yoon KT, Lim TH, Heo J, Tangkijvanich P, Tak WY, Thanawala V, Cloutier D, Mao S, Arizpe A, Cathcart AL, Gupta SV, Hwang C, Gane E.
Yuen MF, et al. Among authors: gupta sv.
Lancet Gastroenterol Hepatol. 2024 Oct 7:S2468-1253(24)00237-1. doi: 10.1016/S2468-1253(24)00237-1. Online ahead of print.
Lancet Gastroenterol Hepatol. 2024.
PMID: 39389081